December 2011

Request Your Free Consultation

FDA Issues Safety Warning for Heart Rhythm Drug Multaq

According to a report from the Injury Board, the heart rhythm drug, Multaq, has been issued a safety warning by the U.S. Food and Drug Administration (FDA). Multaq (dronedarone) was approved in 2009 for the treatment of atrial fibrillation and atrial flutter. Both of these…

Read More

7 Signs of Financial Abuse of the Elderly in Kentucky

Elderly abuse doesn’t just consist of physical harm or neglect. It also can come in the way of financial abuse. In some cases, it could devastate an individual’s finances completely. If you want to know how you can protect your loved one’s rights, then you…

Read More

3 Ways to Prevent a Prescription Drug Mix Up in Kentucky

You may wish to speak with a Kentucky law firm that handles medical malpractice cases if you were injured because of a doctor or pharmacist mistake. Drug mix ups are one way that a patient can suffer serious, even life-threatening injuries. A prescription drug mix…

Read More

How serious is the issue of over prescription in Kentucky and/or in the United States as a whole?

In the United States, the issue of over prescription has become a serious issue. It would stand to reason that it is also an issue here in Kentucky. So this should be kept in the back of any patient’s mind when receiving a prescription. Contact…

Read More

Legal Action against a Company for Mislabeling Supplements

PharmPro reports that legal action is being pursued against a company for mislabeling its supplements. On behalf of the U.S. Food and Drug Administration (FDA), the U.S. Department of Justice has, for the first time, filed an injunction against a supplement maker. This comes as…

Read More

FDA Renews Warning Concerning Dosage in Infant Acetaminophen

ABC News reports that the U.S. Food and Drug Administration (FDA) has renewed a warning concerning dosage errors in liquid infant acetaminophen. In an effort to decrease confusion surrounding the appropriate dosage for infants, one set strength—160 mg/5 mL—was recommended by the FDA in 2009….

Read More